571189-78-1 Usage
General Description
5-morpholinopyridin-2-amine, also known as AM-126, is a chemical compound with the molecular formula C8H11N3O. It is a heterocyclic amine containing a pyridine ring and a morpholine ring. 5-morpholinopyridin-2-amine is a reversible inhibitor of the enzyme fatty acid amide hydrolase (FAAH) and has potential applications in the treatment of pain, inflammation, and neurological disorders. 5-morpholinopyridin-2-amine has been studied for its therapeutic effects on conditions such as neuropathic pain, inflammatory pain, and anxiety. Its unique chemical structure and biological activity make it a promising compound for further research and development in the field of pharmacology and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 571189-78-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,1,1,8 and 9 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 571189-78:
(8*5)+(7*7)+(6*1)+(5*1)+(4*8)+(3*9)+(2*7)+(1*8)=181
181 % 10 = 1
So 571189-78-1 is a valid CAS Registry Number.
571189-78-1Relevant articles and documents
Mild, General, and Regioselective Synthesis of 2-Aminopyridines from Pyridine N -Oxides via N -(2-Pyridyl)pyridinium Salts
Xiong, Hui,Hoye, Adam T.
supporting information, p. 371 - 375 (2022/01/27)
A synthesis of 2-aminopyridines from pyridine N-oxides via their corresponding N-(2-pyridyl)pyridinium salts has been demonstrated and investigated. The reaction sequence features a highly regioselective conversion of the N-oxide into its pyridinium salt
ARYL AND HETEROARYL-CARBOXAMIDE SUBSTITUTED HETEROARYL COMPOUNDS AS TYK2 INHIBITORS
-
, (2021/10/15)
Novel carboxamide substituted compounds of Formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Tyrosine Kinase 2 (Tyk2).
HPK1 ANTAGONISTS AND USES THEREOF
-
Paragraph 0452; 0454; 0457; 0458, (2021/03/19)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
